Filing Details
- Accession Number:
- 0001437749-21-029425
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-29 17:57:12
- Reporting Period:
- 2021-12-27
- Accepted Time:
- 2021-12-29 17:57:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1158895 | Lemaitre Vascular Inc | LMAT | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1365733 | Jr P Joseph Pellegrino | C/O Lemaitre Vascular, Inc. 63 Second Avenue Burlington MA 01803 | Chief Financial Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-27 | 752 | $14.13 | 9,600 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-12-27 | 752 | $52.00 | 8,848 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-12-27 | 55 | $23.56 | 8,903 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-12-27 | 55 | $52.00 | 8,848 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-12-27 | 752 | $0.00 | 752 | $14.13 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-12-27 | 55 | $0.00 | 55 | $23.56 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,844 | 2016-07-25 | 2023-07-25 | No | 4 | M | Direct |
17,411 | 2018-12-19 | 2025-12-19 | No | 4 | M | Direct |
Footnotes
- Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan established by the Reporting Person.
- This option is fully vested and exercisable.
- This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.